These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21763380)

  • 1. Association of osteopontin regulatory polymorphisms with systemic sclerosis.
    Barizzone N; Marchini M; Cappiello F; Chiocchetti A; Orilieri E; Ferrante D; Corrado L; Mellone S; Scorza R; Dianzani U; D'Alfonso S
    Hum Immunol; 2011 Oct; 72(10):930-4. PubMed ID: 21763380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus.
    D'Alfonso S; Barizzone N; Giordano M; Chiocchetti A; Magnani C; Castelli L; Indelicato M; Giacopelli F; Marchini M; Scorza R; Danieli MG; Cappelli M; Migliaresi S; Bigliardo B; Sabbadini MG; Baldissera E; Galeazzi M; Sebastiani GD; Minisola G; Ravazzolo R; Dianzani U; Momigliano-Richiardi P
    Arthritis Rheum; 2005 Feb; 52(2):539-47. PubMed ID: 15692970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.
    Pasha HF; Tantawy EA; Youssef MA
    Gene; 2019 Jun; 702():107-113. PubMed ID: 30898714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.
    Lee YH; Song GG
    Lupus; 2017 Feb; 26(2):132-138. PubMed ID: 27307447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of osteopontin gene variations on multiple sclerosis development and progression.
    Comi C; Cappellano G; Chiocchetti A; Orilieri E; Buttini S; Ghezzi L; Galimberti D; Guerini F; Barizzone N; Perla F; Leone M; D'Alfonso S; Caputo D; Scarpini E; Cantello R; Dianzani U
    Clin Dev Immunol; 2012; 2012():212893. PubMed ID: 23008732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.
    Trivedi T; Franek BS; Green SL; Kariuki SN; Kumabe M; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
    J Biomed Biotechnol; 2011; 2011():802581. PubMed ID: 22131818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.
    Carmona FD; Martin JE; Beretta L; Simeón CP; Carreira PE; Callejas JL; Fernández-Castro M; Sáez-Comet L; Beltrán E; Camps MT; Egurbide MV; ; Airó P; Scorza R; Lunardi C; Hunzelmann N; Riemekasten G; Witte T; Kreuter A; Distler JH; Madhok R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Schuerwegh AJ; Vonk MC; Voskuyl AE; Radstake TR; Martín J
    PLoS One; 2013; 8(1):e54419. PubMed ID: 23372721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.
    Gourh P; Agarwal SK; Martin E; Divecha D; Rueda B; Bunting H; Assassi S; Paz G; Shete S; McNearney T; Draeger H; Reveille JD; Radstake TR; Simeon CP; Rodriguez L; Vicente E; Gonzalez-Gay MA; Mayes MD; Tan FK; Martin J; Arnett FC
    J Autoimmun; 2010 Mar; 34(2):155-62. PubMed ID: 19796918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.
    Kariuki SN; Moore JG; Kirou KA; Crow MK; Utset TO; Niewold TB
    Genes Immun; 2009 Jul; 10(5):487-94. PubMed ID: 19339987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis.
    Koumakis E; Bouaziz M; Dieudé P; Ruiz B; Riemekasten G; Airo P; Müller-Nurasyid M; Cusi D; Matucci-Cerinic M; Melchers I; Salvi E; Strauch K; Peters A; Cuomo G; Hachulla E; Diot E; Hunzelmann N; Caramaschi P; Riccieri V; Distler JH; Tarner I; Avouac J; Letenneur L; Amouyel P; Lambert JC; Chiocchia G; Boileau C; Allanore Y
    Arthritis Rheum; 2013 Dec; 65(12):3202-8. PubMed ID: 23983073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population.
    Chiocchetti A; Orilieri E; Cappellano G; Barizzone N; D' Alfonso S; D' Annunzio G; Lorini R; Ravazzolo R; Cadario F; Martinetti M; Calcaterra V; Cerutti F; Bruno G; Larizza D; Dianzani U
    Int J Immunopathol Pharmacol; 2010; 23(1):263-9. PubMed ID: 20378012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis.
    Koumakis E; Bouaziz M; Dieudé P; Cauvet A; Ruiz B; Airò P; Cusi D; Matucci-Cerinic M; Salvi E; Cuomo G; Hachulla E; Diot E; Caramaschi P; Riccieri V; Avouac J; Allanore Y
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):43-48. PubMed ID: 27385538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Osteopontin gene single nucleotide polymorphism with lupus nephritis.
    Metwally RM; Hasan AS; R EG
    Int J Rheum Dis; 2022 May; 25(5):571-575. PubMed ID: 35218609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wongthanee A; Kuwata S; Takeuchi F
    Int J Rheum Dis; 2021 Nov; 24(11):1378-1385. PubMed ID: 34533895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis.
    Coustet B; Bouaziz M; Dieudé P; Guedj M; Bossini-Castillo L; Agarwal S; Radstake T; Martin J; Gourh P; Elhai M; Koumakis E; Avouac J; Ruiz B; Mayes M; Arnett F; Hachulla E; Diot E; Cracowski JL; Tiev K; Sibilia J; Mouthon L; Frances C; Amoura Z; Carpentier P; Cosnes A; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    J Rheumatol; 2012 May; 39(5):997-1003. PubMed ID: 22422496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
    Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
    Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population.
    Yokoyama N; Kawasaki A; Matsushita T; Furukawa H; Kondo Y; Hirano F; Sada KE; Matsumoto I; Kusaoi M; Amano H; Nagaoka S; Setoguchi K; Nagai T; Shimada K; Sugii S; Hashimoto A; Matsui T; Okamoto A; Chiba N; Suematsu E; Ohno S; Katayama M; Migita K; Kono H; Hasegawa M; Kobayashi S; Yamada H; Nagasaka K; Sugihara T; Yamagata K; Ozaki S; Tamura N; Takasaki Y; Hashimoto H; Makino H; Arimura Y; Harigai M; Sato S; Sumida T; Tohma S; Takehara K; Tsuchiya N
    Sci Rep; 2019 Nov; 9(1):16366. PubMed ID: 31705128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.
    Gourh P; Arnett FC; Tan FK; Assassi S; Divecha D; Paz G; McNearney T; Draeger H; Reveille JD; Mayes MD; Agarwal SK
    Ann Rheum Dis; 2010 Mar; 69(3):550-5. PubMed ID: 19778912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.
    Tozkır JD; Tozkır H; Gürkan H; Dönmez S; Eker D; Pamuk GE; Pamuk ÖN
    Clin Rheumatol; 2016 Apr; 35(4):919-25. PubMed ID: 26960450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.